Special Issue "Antivirals"


A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (31 July 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Ulrich Jordis
Institute of Applied Synthetic Chemistry, Vienna University of Technology, Getreidemarkt 9/163, A-1060 Wien, Austria
Website: http://phoenix.tuwien.ac.at/
E-Mail: ulrich.jordis@tuwien.ac.at
Phone: +43 1 58801 15460
Fax: +43 1 58801 15499
Interests: antivirals; Alzheimer; quinolones; combinatorial chemistry; labelled compounds; natural products (alkaloids; triterpenes); custom synthesis; chemistry software and databases

Special Issue Information

Dear Colleagues,

Molecules and Pharmaceuticals, being pioneer journals of web-based publications, invites you to submit research articles and comprehensive reviews addressing the discovery and/or development of antiviral agents in animals and man as well as in plants or lower organisms. Despite the tremendous successes and hallmarks e.g. in treating AIDS, clearly there is an ongoing and increased challenge to cope with the evolutionary and constantly changing threats of viral infections that have even the potential to ultra-risks for the mankind. Natural products continue to provide important leads and structures for the development of antiviral compounds and insights into the biochemical pathways and cell live cycles provide new starting points for new antiviral mechanisms. This issue intends to delineate the efforts being made to develop new and effective broad-spectrum antiviral agents e.g. for the treatment of HSV, VZV, HIV, HBV and DNA virus infections.

Prof. Dr. Ulrich Jordis
Guest Editor

Related Special Issue

Published Papers (3 papers)

Pharmaceuticals 2011, 4(12), 1518-1534; doi:10.3390/ph4121518
Received: 31 August 2011; in revised form: 16 November 2011 / Accepted: 18 November 2011 / Published: 25 November 2011
Show/Hide Abstract | Cited by 2 | PDF Full-text (3893 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2011, 4(7), 1019-1031; doi:10.3390/ph4071019
Received: 8 June 2011; in revised form: 30 June 2011 / Accepted: 7 July 2011 / Published: 13 July 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (67 KB) | HTML Full-text | XML Full-text

Pharmaceuticals 2010, 3(10), 3343-3354; doi:10.3390/ph3103343
Received: 2 September 2010; in revised form: 23 October 2010 / Accepted: 25 October 2010 / Published: 25 October 2010
Show/Hide Abstract | Cited by 4 | PDF Full-text (607 KB) | HTML Full-text | XML Full-text

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert